Basis: Four-quarter operating cash flow / FMP quote market capitalization × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The operating cash flow yield is N/A as of 2026-10-06T20:56:28.001Z.
Calculation as of: 2026-10-06T20:56:28.001Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: f06204e81c8a2ed41a5798160e844c591f5150b644efe168084329023db9ebc4
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
OPERATING CASH FLOW YIELD
N/A
DiaMedica Therapeutics Inc.
Market Cap
$438.07M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$439.55M
Operating Cash Flow Yield
N/A
TTM Avg
28.93%
3Y Avg
28.93%
5Y Avg
28.93%
Market Cap
$435.61M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$442.34M
Operating Cash Flow Yield
N/A
TTM Avg
52.36%
3Y Avg
52.36%
5Y Avg
52.36%
Market Cap
$431.97M
Operating Cash Flow Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$445.71M
Operating Cash Flow Yield
N/A
TTM Avg
7.13%
3Y Avg
7.13%
5Y Avg
7.13%
Market Cap
$426.51M
Operating Cash Flow Yield
N/A
TTM Avg
1.02%
3Y Avg
1.02%
5Y Avg
1.02%
Market Cap
$424.10M
Operating Cash Flow Yield
5.20%
TTM Avg
5.09%
3Y Avg
4.22%
5Y Avg
4.07%
Market Cap
$452.54M
Operating Cash Flow Yield
6.52%
TTM Avg
6.70%
3Y Avg
7.02%
5Y Avg
5.84%
| NAME | MARKET CAP | OPERATING CASH FLOW YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| DiaMedica Therapeutics Inc. (DMAC) | $438.07M | N/A | N/A | N/A | N/A |
| Assembly Biosciences, Inc. (ASMB)vs › | $439.55M | N/A | 28.93% | 28.93% | 28.93% |
| YD Bio Limited Ordinary Shares (YDES)vs › | $435.61M | N/A | N/A | N/A | N/A |
| Ovid Therapeutics Inc. (OVID)vs › | $442.34M | N/A | 52.36% | 52.36% | 52.36% |
| NeuroPace, Inc. (NPCE)vs › | $431.97M | N/A | N/A | N/A | N/A |
| Capricor Therapeutics, Inc. (CAPR)vs › | $445.71M | N/A | 7.13% | 7.13% | 7.13% |
| ARS Pharmaceuticals, Inc. (SPRY)vs › | $426.51M | N/A | 1.02% | 1.02% | 1.02% |
| NeoGenomics, Inc. (NEO)vs › | $424.10M | 5.20% | 5.09% | 4.22% | 4.07% |
| NRC Health (NRC)vs › | $452.54M | 6.52% | 6.70% | 7.02% | 5.84% |
| Tectonic Therapeutic, Inc. (TECX)vs › | $422.86M | N/A | N/A | N/A | N/A |
OCF Yield = TTM Operating Cash Flow / Market Cap
Operating cash flow yield is the inverse of P/OCF, expressing trailing operating cash flow as a percentage of price. It sits between earnings yield (before non-cash accrual effects) and FCF yield (before capital expenditure).
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
